Astrocytic transporters in Alzheimer's disease

Multidrug resistance in cancer: role of ATP–dependent transporters

Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536 · see citing works

Astrocytes: Biology and pathology

Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Glutamate uptake

Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,068 · see citing works

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · see citing works

A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function

Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · see citing works

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · see citing works

Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · see citing works

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · see citing works

The Cellular Phase of Alzheimer’s Disease

De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works

Astrocytes, from brain glue to communication elements: the revolution continues

Volterra, A., & Meldolesi, J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1722 · Cited by 1,763 · see citing works

Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation

Suzuki, A., Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti, P. J., & Alberini, C. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.018 · Cited by 1,711 · see citing works

The role of apolipoprotein E in Alzheimer's disease

Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works

Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters

Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., & Gouaux, E. (2005) · Nature · doi:10.1038/nature03978 · Cited by 1,660 · see citing works

Sugar transporters for intercellular exchange and nutrition of pathogens

Chen, L., Hou, B., Lalonde, S., Takanaga, H., Hartung, M. L., Qu, X.-Q., Guo, W., Kim, J., Underwood, W. R., Chaudhuri, B., et al. (2010) · Nature · doi:10.1038/nature09606 · Cited by 1,629 · see citing works

Sugar for the brain: the role of glucose in physiological and pathological brain function

Mergenthaler, P., Lindauer, U., Dienel, G. A., & Meisel, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.001 · Cited by 1,612 · see citing works

Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · see citing works

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · see citing works

The GLUT4 Glucose Transporter

Huang, S., & Czech, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,399 · see citing works

The SLC2 (GLUT) family of membrane transporters

Mueckler, M., & Thorens, B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.001 · Cited by 1,328 · see citing works

Astrocyte Control of Synaptic Transmission and Neurovascular Coupling

Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,326 · see citing works

Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · see citing works

Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model

Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216 · see citing works

Biochemistry of Na,K-ATPase

Kaplan, J. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102201.141218 · Cited by 1,181 · see citing works

Neurotransmitter Transporters: Recent Progress

Amara, S., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,088 · see citing works

GFAP in health and disease

Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080 · see citing works

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease

HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938 · see citing works

Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 900 · see citing works

SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation

Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 865 · see citing works

Mechanisms of Disease: astrocytes in neurodegenerative disease

Maragakis, N., & Rothstein, J. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0355 · Cited by 834 · see citing works

Cloning and expression of a functional serotonin transporter from rat brain

Blakely, R., Berson, H. E., Fremeau, R. T., Caron, M. G., Peek, M. M., Prince, H. K., & Bradley, C. C. (1991) · Nature · doi:10.1038/354066a0 · Cited by 831 · see citing works

Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress

Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 786 · see citing works

Structure of a glutamate transporter homologue from Pyrococcus horikoshii

Yernool, D., Boudker, O., Jin, Y., & Gouaux, E. (2004) · Nature · doi:10.1038/nature03018 · Cited by 784 · see citing works

The SLC16 gene family – Structure, role and regulation in health and disease

Halestrap, A. P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.05.003 · Cited by 768 · see citing works

Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness

Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741 · see citing works

A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes

Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, Á., Tanaka, K., & Niwa, M. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.002 · Cited by 728 · see citing works

Sweet Sixteen for ANLS

Pellerin, L., & Magistretti, P. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.149 · Cited by 726 · see citing works

Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?

Lewerenz, J., & Maher, P. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00469 · Cited by 721 · see citing works

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689 · see citing works

The SLC3 and SLC7 families of amino acid transporters

Fotiadis, D., Kanai, Y., & Palacı́n, M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.007 · Cited by 674 · see citing works

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies

Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 671 · see citing works

Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain

Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668 · see citing works

P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660 · see citing works

Astrocyte glycogen and brain energy metabolism

Brown, A. M., & Ransom, B. R. (2007) · Glia · doi:10.1002/glia.20557 · Cited by 626 · see citing works

Is Alzheimer’s disease a type 3 diabetes? A critical appraisal

Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works

The MRP family of drug efflux pumps

Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 615 · see citing works

Brain fuel metabolism, aging, and Alzheimer’s disease

Cunnane, S. C., Nugent, S., Roy, M., Courchesne‐Loyer, A., Croteau, É., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 607 · see citing works

Modeling familial Alzheimer's disease with induced pluripotent stem cells

Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599 · see citing works

Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease

Mosconi, L., Pupi, A., & de Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 599 · see citing works

GABA TRANSPORTER HETEROGENEITY: PHARMACOLOGY AND CELLULAR LOCALIZATION

Borden, L. A. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00158-1 · Cited by 596 · see citing works

Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease

Kapogiannis, D., & Mattson, M. P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70277-5 · Cited by 594 · see citing works

System x c ‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS

Bridges, R. J., Natale, N. R., & Patel, S. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01480.x · Cited by 542 · see citing works

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial

Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532 · see citing works

Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies

Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532 · see citing works

Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease

Olabarria, M., Noristani, H. N., Verkhratsky, A., & Rodríguez, J. J. (2010) · Glia · doi:10.1002/glia.20967 · Cited by 499 · see citing works

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease

Simpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490 · see citing works

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

Mosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y., Pirraglia, E., De Santi, S., Reisberg, B., Wisniewski, T., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1039-z · Cited by 487 · see citing works

Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway

Almeida, Á., Moncada, S., & Bolaños, J. P. (2003) · Nature Cell Biology · doi:10.1038/ncb1080 · Cited by 481 · see citing works

Brain lactate metabolism: the discoveries and the controversies

Dienel, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.175 · Cited by 479 · see citing works

Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476 · see citing works

Astrocytes in Alzheimer's Disease

Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C., & Rodriguez, J. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.017 · Cited by 453 · see citing works

Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase

McGrail, K., Phillips, J., & Sweadner, K. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00381.1991 · Cited by 449 · see citing works

Astrocyte Ca2+ signalling: an unexpected complexity

Volterra, A., Liaudet, N., & Savtchouk, I. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3725 · Cited by 446 · see citing works

Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

Beart, P., & O'Shea, R. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706949 · Cited by 419 · see citing works

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition

Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404 · see citing works

Specification of transplantable astroglial subtypes from human pluripotent stem cells

Krencik, R., Weick, J. P., Liu, Y., Zhang, Z., & Zhang, S. (2011) · Nature Biotechnology · doi:10.1038/nbt.1877 · Cited by 401 · see citing works

Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics

Kim, K., Lee, S., Kegelman, T. P., Su, Z.-Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P. W., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22609 · Cited by 396 · see citing works

Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction

Orre, M., Kamphuis, W., Osborn, L. M., Jansen, A. H. P., Kooijman, L., Bossers, K., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.004 · Cited by 394 · see citing works

Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population‐Based Case–Control Study

Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03916.x · Cited by 389 · see citing works

Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain

Nies, A. T., Jedlitschky, G., König, J., Herold‐Mende, C. C., Steiner, H. H., Schmitt, H.-P., & KEPPLER, D. O. R. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 381 · see citing works

Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain

Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381 · see citing works

β‐Amyloid efflux mediated by p‐glycoprotein

Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 379 · see citing works

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378 · see citing works

The glial cell glutamate uptake carrier countertransports pH-changing anions

Bouvier, M., Szatkowski, M. S., Amato, A., & Attwell, D. (1992) · Nature · doi:10.1038/360471a0 · Cited by 374 · see citing works

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

Hsu, C.-C., Wahlqvist, M. L., Lee, M.-S., & Tsai, H.-N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101524 · Cited by 372 · see citing works

Rat model of perinatal hypoxic-ischemic brain damage

Vannucci, R. C., Connor, J. R., Mauger, D. T., Palmer, C., Smith, M. B. H., Towfighi, J., & Vannucci, S. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990115)55:2 · Cited by 370 · see citing works

Mechanisms of Glutamate Transport

Vandenberg, R. J., & Ryan, R. M. (2013) · Physiological Reviews · doi:10.1152/physrev.00007.2013 · Cited by 349 · see citing works

Glutamate Transporter Alterations in Alzheimer Disease Are Possibly Associated with Abnormal APP Expression

LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343 · see citing works

Glutamate dysfunction in Alzheimer's disease: an hypothesis

Maragos, W. F., Greenamyre, J. T., Penney, J. B., & Young, A. B. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90025-7 · Cited by 334 · see citing works

Glycine transporters: essential regulators of neurotransmission

Eulenburg, V., Armsen, W., Betz, H., & Gomeza, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.04.004 · Cited by 327 · see citing works

Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer’s Disease

Hartz, A. M. S., Miller, D. S., & Bauer, B. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061754 · Cited by 320 · see citing works

Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling

Abdul, H. M., Sama, M. A., Furman, J. L., Mathis, D. M., Beckett, T. L., Weidner, A. M., Patel, E., Baig, I., Murphy, M. P., LeVine, H., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1064-09.2009 · Cited by 319 · see citing works

Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes

Lee, S., Su, Z. Z., Emdad, L., Gupta, P., Sarkar, D., Borjabad, A., Volsky, D. J., & Fisher, P. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707697200 · Cited by 318 · see citing works

Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

Jacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317 · see citing works

Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation

Shih, A. Y., Erb, H., Sun, X., Toda, S., Kalivas, P. W., & Murphy, T. H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3178-06.2006 · Cited by 315 · see citing works

Glutamate Transporter Coupling to Na,K-ATPase

Rose, E., Koo, J. C. P., Antflick, J. E., Ahmed, S. M., Angers, S., & Hampson, D. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1081-09.2009 · Cited by 311 · see citing works

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., & Van Leuven, F. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-22 · Cited by 309 · see citing works

Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer’s disease model

Wu, Z., Guo, Z., Gearing, M., & Chen, G. (2014) · Nature Communications · doi:10.1038/ncomms5159 · Cited by 306 · see citing works

Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment

Lombardo, S., & Maskos, U. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.018 · Cited by 303 · see citing works

Directed differentiation of functional astroglial subtypes from human pluripotent stem cells

Krencik, R., & Zhang, S. (2011) · Nature Protocols · doi:10.1038/nprot.2011.405 · Cited by 300 · see citing works

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

Huey, E. D., Putnam, K. T., & Grafman, J. (2006) · Neurology · doi:10.1212/01.wnl.0000191304.55196.4d · Cited by 299 · see citing works

Glucose transport families SLC5 and SLC50

Wright, E. M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.002 · Cited by 295 · see citing works

Dynamic Equilibrium of Neurotransmitter Transporters: Not Just for Reuptake Anymore

Richerson, G. B., & Wu, Y. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00317.2003 · Cited by 292 · see citing works

Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory

Orr, A. G., Hsiao, E. C., Wang, M. M., Ho, K., Kim, D. H., Wang, X., Guo, W., Kang, J., Yu, G.-Q., Adame, A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3930 · Cited by 289 · see citing works

Deficiency in Na,K-ATPase α Isoform Genes Alters Spatial Learning, Motor Activity, and Anxiety in Mice

Moseley, A. E., Williams, M. T., Schaefer, T. L., Bohanan, C. S., Neumann, J. C., Behbehani, M. M., Vorhees, C. V., & Lingrel, J. B. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4464-06.2007 · Cited by 288 · see citing works

The Glutamatergic System and Alzheimer???s Disease

Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267 · see citing works

The Concise Guide to PHARMACOLOGY 2015/16: Transporters

Alexander, S. P. H., Kelly, E., Marrion, N. V., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13355 · Cited by 267 · see citing works

Bioenergetics and redox adaptations of astrocytes to neuronal activity

Bolaños, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13486 · Cited by 262 · see citing works

The Transporter Classification (TC) System, 2002

Busch, W., & Saier, M. H. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771528 · Cited by 259 · see citing works

The Regulation of Glucose Metabolism by HIF-1 Mediates a Neuroprotective Response to Amyloid Beta Peptide

Soucek, T., Cumming, R., Dargusch, R., Maher, P., & Schubert, D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00367-2 · Cited by 258 · see citing works

5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease

Upton, N., Chuang, T. T., Hunter, A. J., & Virley, D. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.008 · Cited by 257 · see citing works

Astrocyte heterogeneity

Wilkin, G. P., Marriott, D. R., & Cholewinski, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90065-i · Cited by 255 · see citing works

Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests

Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.96 · Cited by 247 · see citing works

The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus

Dawson, L. A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00265-2 · Cited by 245 · see citing works

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

Cudkowicz, M., Titus, S., Kearney, M., Yu, H., Sherman, A., Schoenfeld, D., Hayden, D., Shui, A. M., Brooks, B. R., CONWIT, R. A., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70222-4 · Cited by 243 · see citing works

Glutamatergic systems in Alzheimer's disease

Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 242 · see citing works

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

Kepe, V., Barrio, J. R., Huang, S., Ercoli, L. M., Siddarth, P., Shoghi, K. I., Cole, G. M., Satyamurthy, N., Cummings, J. L., Small, G. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510237103 · Cited by 241 · see citing works

Cell-specific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy

Pierre, K., Pellerin, L., Debernardi, R., Riederer, B., & Magistretti, P. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00294-3 · Cited by 238 · see citing works

Evidence for impaired amyloid β clearance in Alzheimer's disease

Wildsmith, K. R., Holley, M. M., Savage, J. C., Skerrett, R., & Landreth, G. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt187 · Cited by 235 · see citing works

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells

Juopperi, T. A., Kim, W. R., Chiang, C.-H., Yu, H., Margolis, R. L., Ross, C. A., Ming, G., & Song, H. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-17 · Cited by 228 · see citing works

How many neurons do you have? Some dogmas of quantitative neuroscience under revision

Lent, R., Azevedo, F. A. C., Andrade-Moraes, C. H., & de Oliveira-Pinto, A. V. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07923.x · Cited by 225 · see citing works

Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice

Merlini, M., Meyer, E. P., Ulmann-Schuler, A., & Nitsch, R. M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0834-y · Cited by 225 · see citing works

Sodium dynamics: another key to astroglial excitability?

Kirischuk, S., Parpura, V., & Verkhratsky, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.003 · Cited by 223 · see citing works

Drug discovery in dementia: the role of rodent models

Dam, D. V., & Deyn, P. P. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2075 · Cited by 220 · see citing works

Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease

Palmer, A. M., Francis, P. T., Benton, J. S., Sims, N. R., Mann, D. M. A., Neary, D., Snowden, J. S., & Bowen, D. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb13120.x · Cited by 214 · see citing works

Noradrenergic dysfunction in Alzheimer's disease

Gannon, M. A., Che, P., Chen, Y., Jiao, K., Roberson, E. D., & Wang, Q. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00220 · Cited by 211 · see citing works

Glutamate Uptake Stimulates Na+,K+‐ATPase Activity in Astrocytes via Activation of a Distinct Subunit Highly Sensitive to Ouabain

Pellerin, L., & Magistretti, P. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052132.x · Cited by 210 · see citing works

Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors

Mota, S. I., Ferreira, I. L., & Rego, A. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206 · see citing works

Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?

Olabarria, M., Noristani, H. N., Verkhratsky, A., & Rodriguez, J. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-55 · Cited by 199 · see citing works

GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease

Mooradian, A. D., Chung, H. C., & Shah, G. N. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00111-5 · Cited by 199 · see citing works

Co-compartmentalization of the Astroglial Glutamate Transporter, GLT-1, with Glycolytic Enzymes and Mitochondria

Genda, E. N., Jackson, J. G., Sheldon, A. L., Locke, S. F., Greco, T. M., O’Donnell, J. C., Spruce, L. A., Xiao, R., Guo, W., Putt, M. E., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3305-11.2011 · Cited by 195 · see citing works

Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer’s pathology and APOE genotype

Simpson, J. E., Ince, P. G., Shaw, P. J., Heath, P. R., Raman, R., Garwood, C. J., Gelsthorpe, C., Baxter, L., Forster, G., Matthews, F. E., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.013 · Cited by 188 · see citing works

Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9

Bussière, T., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10760 · Cited by 185 · see citing works

Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxonein vitro

Lewerenz, J., Albrecht, P., Tien, M. T., Henke, N., Karumbayaram, S., Kornblum, H. I., Wiedau‐Pazos, M., Schubert, D., Maher, P. A., & Methner, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06347.x · Cited by 174 · see citing works

Current approaches to enhance glutamate transporter function and expression

Fontana, A. C. K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13200 · Cited by 171 · see citing works

Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?

Palmer, A. M., & Gershon, S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2165009 · Cited by 170 · see citing works

GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model

Mookherjee, P., Green, P. S., Watson, G. S., Marques, M. A., Tanaka, K., Meeker, K. D., Meabon, J. S., Li, N., Zhu, P., Olson, V. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110503 · Cited by 164 · see citing works

The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease

Sato, N., & Morishita, R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00199 · Cited by 164 · see citing works

Optogenetics and the future of neuroscience

Boyden, E. S. (2015) · Nature Neuroscience · doi:10.1038/nn.4094 · Cited by 163 · see citing works

Na+ and K+ ion imbalances in Alzheimer's disease

Vitvitsky, V., Garg, S. K., Keep, R. F., Albin, R. L., & Banerjee, R. V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.004 · Cited by 162 · see citing works

Selectivity of Digitalis Glycosides for Isoforms of Human Na,K-ATPase

Katz, A., Lifshitz, Y., Bab-Dinitz, E., Kapri-Pardes, E., Goldshleger, R., Tal, D. M., & KARLISH, S. J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119248 · Cited by 161 · see citing works

The Role of P-glycoprotein in Cerebral Amyloid Angiopathy; Implications for the Early Pathogenesis of Alzheimers Disease

Vogelgesang, S., Warzok, R., Cascorbi, I., Kunert‐Keil, C., Schroeder, E., Kroemer, H. K., Siegmund, W., Walker, L. C., & Pahnke, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332225 · Cited by 160 · see citing works

Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells

Kim, W., Guillemin, G., Glaros, E., Lim, C. K., & Garner, B. (2006) · NeuroReport · doi:10.1097/01.wnr.0000221833.41340.cd · Cited by 158 · see citing works

Glia in the pathogenesis of neurodegenerative diseases

Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., & Sofroniew, M. V. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140107 · Cited by 157 · see citing works

Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease

Takahashi, K., Kong, Q., Lin, Y., Stouffer, N., Schulte, D. A., Lai, L., Liu, Q., Chang, L., Dominguez, S., Xing, X., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20140413 · Cited by 157 · see citing works

Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.

Bowen, D. M., Najlerahim, A., Procter, A. W., Francis, P. T., & Murphy, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9504 · Cited by 157 · see citing works

Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection

Kong, Q., Chang, L.-C., Takahashi, K., Liu, Q., Schulte, D. A., Lai, L., Ibabao, B., Lin, Y., Stouffer, N., Mukhopadhyay, C. D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66163 · Cited by 156 · see citing works

Glucose Transporter Expression in Brain: Relationship to Cerebral Glucose Utilization

Vannucci, S. J., Clark, R. R., Koehler-Stec, E. M., Li, K., Smith, C. B., Davies, P., Maher, F., & Simpson, I. A. (1998) · Developmental Neuroscience · doi:10.1159/000017333 · Cited by 153 · see citing works

Oxidatively Modified GST and MRP1 in Alzheimer?s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products

Sultana, R., & Butterfield, D. A. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7028-0 · Cited by 153 · see citing works

Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease

Zumkehr, J., Rodríguez‐Ortiz, C. J., Cheng, D., Kieu, Z., Wai, T., Hawkins, C., Kilian, J., Lim, S., Medeiros, R., & Kitazawa, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.005 · Cited by 152 · see citing works

Differential Involvement of 5-HT1B/1D and 5-HT6 Receptors in Cognitive and Non-cognitive Symptoms in Alzheimer's Disease

Garcı́a-Alloza, M., Hirst, W. D., Chen, C., Lasheras, B., Francis, P. T., & Ramírez, M. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300330 · Cited by 151 · see citing works

Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study

Rodriguez‐Vieitez, E., Ni, R., Gulyás, B. Z., Tóth, M., Häggkvist, J., Halldin, C., Voytenko, L. P., Marutle, A., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3047-0 · Cited by 149 · see citing works

Relevance of Transgenic Mouse Models to Human Alzheimer Disease

Morrissette, D. A., Parachikova, A. I., Green, K. N., & LaFerla, F. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 147 · see citing works

ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology

Sakae, N., Liu, C., Shinohara, M., Frisch‐Daiello, J. L., Ma, L., Yamazaki, Y., Tachibana, M., Younkin, L. H., Kurti, A., Carrasquillo, M. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3757-15.2016 · Cited by 146 · see citing works

Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice

Masliah, E., Alford, M. F., Mallory, M. E., Rockenstein, E. M., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7386 · Cited by 145 · see citing works

Astroglia dynamics in ageing and Alzheimer's disease

Verkhratsky, A., Zorec, R., Rodriguez, J. J., & Parpura, V. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.011 · Cited by 145 · see citing works

Association of the Serotonin Transporter and Receptor Gene Polymorphisms in Neuropsychiatric Symptoms in Alzheimer Disease

Assal, F., Alarcón, M., Solomon, E., Masterman, D. L., Geschwind, D. H., & Cummings, J. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1249 · Cited by 142 · see citing works

Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood–brain barrier

Soontornmalai, A., Vlaming, M. L. H., & Fritschy, J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.011 · Cited by 141 · see citing works

Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells

Lee, J. O., Lee, S. K., Kim, J. H., Kim, N., You, G. Y., Moon, J. W., Kim, S. J., Park, S. H., & Kim, H. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.361386 · Cited by 140 · see citing works

Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly

Ohnishi, T., Yanazawa, M., Sasahara, T., Kitamura, Y., Hiroaki, H., Fukazawa, Y., Kii, I., Nishiyama, T., Kakita, A., Takeda, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421182112 · Cited by 139 · see citing works

Astrocytes and Glutamate Homoeostasis in Alzheimer’s Disease: A Decrease in Glutamine Synthetase, But Not in Glutamate Transporter-1, in the Prefrontal Cortex

Kulijewicz‐Nawrot, M., Syková, E., Chvátal, A., Verkhratsky, A., & Rodriguez, J. J. (2013) · ASN NEURO · doi:10.1042/an20130017 · Cited by 138 · see citing works

Visualising the activity of the cystine‐glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate

Pow, D. V. (2001) · Glia · doi:10.1002/glia.1037 · Cited by 137 · see citing works

Cl−-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains

Hattori, N., Kitagawa, K., Higashida, T., Yagyu, K., Shimohama, S., Wataya, T., Perry, G., Smith, M. A., & Inagaki, C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00654-5 · Cited by 137 · see citing works

Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells

Harris, F. M., Tesseur, I., Brecht, W. J., Xu, Q., Mullendorff, K., Chang, S., Wyss-Coray, T., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309475200 · Cited by 135 · see citing works

Nonvesicular Release of Glutamate by Glial xCT Transporters Suppresses Glutamate Receptor ClusteringIn Vivo

Augustin, H., Grosjean, Y., Chen, K., Sheng, Q., & Featherstone, D. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4770-06.2007 · Cited by 133 · see citing works

Brain-Derived Neurotrophic Factor Stimulates Energy Metabolism in Developing Cortical Neurons

Burkhalter, J., Fiumelli, H., Allaman, I., Chatton, J., & Martin, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08212.2003 · Cited by 133 · see citing works

The Pro-inflammatory Cytokine TNF-α Regulates the Activity and Expression of the Serotonin Transporter (SERT) in Astrocytes

Malynn, S., Campos‐Torres, A., Moynagh, P. N., & Haase, J. K. (2013) · Neurochemical Research · doi:10.1007/s11064-012-0967-y · Cited by 125 · see citing works

Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction

Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 124 · see citing works

FXYD Proteins: New Tissue-Specific Regulators of the Ubiquitous Na,K-ATPase

Crambert, G., & Geering, K. (2003) · Science s STKE · doi:10.1126/stke.2003.166.re1 · Cited by 124 · see citing works

Inhibitory Interneuron Progenitor Transplantation Restores Normal Learning and Memory in ApoE4 Knock-In Mice without or with Aβ Accumulation

Tong, L. M., Djukic, B., Arnold, C., Gillespie, A. K., Yoon, S. Y., Wang, M. M., Zhang, O., Knoferle, J., Rubenstein, J. L. R., Alvarez-Buylla, A., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0693-14.2014 · Cited by 123 · see citing works

Neurotrophins regulate the function of cultured microglia

Nakajima, K., Kikuchi, Y., Ikoma, E., Honda, S., Ishikawa, M., Liu, Y., & Kohsaka, S. (1998) · Glia · doi:10.1002/(sici)1098-1136(199811)24:3 · Cited by 122 · see citing works

A Functional Role for Sodium-Dependent Glucose Transport across the Blood-Brain Barrier during Oxygen Glucose Deprivation

Vemula, S., Roder, K. E., Yang, T., Bhat, G. J., Thekkumkara, T., & Abbruscato, T. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146589 · Cited by 119 · see citing works

ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies

Boehm-Cagan, A., Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., & Michaelson, D. M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160467 · Cited by 116 · see citing works

The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke

Thöne‐Reineke, C., Neumann, C., Namsolleck, P., Schmerbach, K., Krikov, M., Schefe, J. H., Lucht, K., Hörtnagl, H., Godes, M., Müller, S., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328313e403 · Cited by 115 · see citing works

Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo

Hanu, R., McKenna, M. C., O’Neill, A., Resneck, W. G., & Bloch, R. J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.5.c921 · Cited by 114 · see citing works

A disorder of cortical GABAergic innervation in Alzheimer's disease

Hardy, J., Cowburn, R. F., BARTON, A. J. L., Reynolds, G. P., Dodd, P. R., Wester, P. O., O’Carroll, A., Lofdahl, E., & Winblad, B. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90016-4 · Cited by 114 · see citing works

Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions

Nijland, P. G., Michailidou, I., Witte, M. E., Mizee, M. R., van der Pol, S. M. A., Hof, B. V. H., Reijerkerk, A., Pellerin, L., van der Valk, P., de Vries, H. E., et al. (2014) · Glia · doi:10.1002/glia.22667 · Cited by 113 · see citing works

Two sides of the same coin: Sodium homeostasis and signaling in astrocytes under physiological and pathophysiological conditions

Rose, C. R., & Karus, C. (2013) · Glia · doi:10.1002/glia.22492 · Cited by 112 · see citing works

Hypoxia Suppresses Glutamate Transport in Astrocytes

Dallas, M. L., Boycott, H. E., Atkinson, L., Miller, A., Boyle, J. P., Pearson, H. A., & Peers, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5030-06.2007 · Cited by 111 · see citing works

Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila

Niccoli, T., Cabecinha, M., Tillmann, A., Kerr, F., Wong, C. T., Cardenes, D., Vincent, A. J., Bettedi, L., Li, L., Grönke, S., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.017 · Cited by 111 · see citing works

Chapter 21 Glutamate toxicity in chronic neurodegenerative disease

Lancelot, E., & Beal, M. F. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60446-x · Cited by 110 · see citing works

Presenilin-1 L166P Mutant Human Pluripotent Stem Cell–Derived Neurons Exhibit Partial Loss of γ-Secretase Activity in Endogenous Amyloid-β Generation

Koch, P., Tamboli, I. Y., Mertens, J., Wunderlich, P., Ladewig, J., Stüber, K., Esselmann, H., Wiltfang, J., Brüstle, O., & Walter, J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.02.012 · Cited by 110 · see citing works

Region- and Age-Specific Changes in Glutamate Transport in the AβPP23 Mouse Model for Alzheimer's Disease

Schallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109 · see citing works

Decreased CSF Concentrations of Homovanillic Acid and γ-Aminobutyric Acid in Alzheimer's Disease

Bareggi, S. R. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510230035010 · Cited by 107 · see citing works

System xC− is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice

Mesci, P., Zaïdi, S., Lobsiger, C. S., Millecamps, S., Escartin, C., Seilhean, D., Sato, H., Mallat, M., & Boillée, S. (2014) · Brain · doi:10.1093/brain/awu312 · Cited by 107 · see citing works

Learning-Induced Gene Expression in the Hippocampus Reveals a Role of Neuron -Astrocyte Metabolic Coupling in Long Term Memory

Tadi, M., Allaman, I., Lengacher, S., Grenningloh, G., & Magistretti, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141568 · Cited by 106 · see citing works

Metformin Facilitates Amyloid-β Generation by β- and γ -Secretases via Autophagy Activation

Son, S. M., Shin, H., Byun, J., Kook, S. Y., Moon, M., Chang, Y. J., & Mook‐Jung, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151200 · Cited by 106 · see citing works

ABC Transporters and the Alzheimer’s Disease Enigma

Wolf, A. M., Bauer, B., & Hartz, A. M. S. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00054 · Cited by 105 · see citing works

Main path and byways: non‐vesicular glutamate release by system xc−as an important modifier of glutamatergic neurotransmission

Massie, A., Boillée, S., Hewett, S. J., Knackstedt, L. A., & Lewerenz, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13348 · Cited by 103 · see citing works

Characterization of astrocyte‐specific conditional knockouts

Casper, K. B., Jones, K. A., & McCarthy, K. D. (2007) · genesis · doi:10.1002/dvg.20287 · Cited by 103 · see citing works

Optogenetic experimentation on astrocytes

Figueiredo, M., Lane, S., Tang, F., Liu, B., Hewinson, J., Marina, N., Kasymov, V., Souslova, E. A., Chudakov, D. M., Gourine, A. V., et al. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2010.052597 · Cited by 102 · see citing works

RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases

van Neerven, S., Kampmann, E., & Mey, J. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.006 · Cited by 101 · see citing works

Neuronal histamine and cognitive symptoms in Alzheimer's disease

Zlomuzica, A., Dere, D., Binder, S., Silva, M. A. D. S., Huston, J. P., & Dere, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.007 · Cited by 99 · see citing works

VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux

Mohler, E. G., Shacham, S., Noiman, S., Lezoualc’h, F., Robert, S. J., Gastineau, M., Rutkowski, J., Marantz, Y., Dumuis, A., Bockaert, J., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.016 · Cited by 98 · see citing works

Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease

Li, T., Holmes, C., Sham, P. C., Vallada, H., Birkett, J., Kirov, G., Lesch, K., Powell, J. F., Lovestone, S., & Collier, D. (1997) · Neuroreport · doi:10.1097/00001756-199702100-00021 · Cited by 98 · see citing works

GABA transporters as drug targets for modulation of GABAergic activity

Schousboe, A., Sarup, A., Larsson, O. M., & White, H. S. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.041 · Cited by 96 · see citing works

Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system

Hewett, J. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06288.x · Cited by 94 · see citing works

Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression

Li, Y., Sattler, R., Yang, E. J., Nunes, A., Ayukawa, Y., Akhtar, S., Ji, G., Zhang, P.-W., & Rothstein, J. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.016 · Cited by 93 · see citing works

N a+‐ K +‐ ATP ase, a potent neuroprotective modulator against A lzheimer disease

Zhang, L., Sun, Y., Pan, S., Li, J., Qu, Y., Li, Y., Wang, Y., & Gao, Z. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12000 · Cited by 92 · see citing works

Serotonergic Therapies for Cognitive Symptoms in Alzheimer’s Disease: Rationale and Current Status

Ramírez, M. J., Lai, M. K. P., Tordera, R. M., & Francis, P. T. (2014) · Drugs · doi:10.1007/s40265-014-0217-5 · Cited by 92 · see citing works

Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes

Mercier, C., Masseguin, C., Roux, F. S., Gabrion, J., & Scherrmann, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.034 · Cited by 91 · see citing works

Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities

Jensen, A. A., Fahlke, C. M., Bjørn-Yoshimoto, W. E., & Bunch, L. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.008 · Cited by 88 · see citing works

Glucose metabolism and astrocyte–neuron interactions in the neonatal brain

Brekke, E., Morken, T. S., & Sonnewald, U. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.02.002 · Cited by 88 · see citing works

Pharmacological characterization and visualization of the glial serotonin transporter

Inazu, M., Takeda, H., Ikoshi, H., Sugisawa, M., Uchida, Y., & Matsumiya, T. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00010-9 · Cited by 87 · see citing works

Glutamate transporter expression and function in human glial progenitors

Maragakis, N. J., Dietrich, J., Wong, V., Xue, H., Mayer‐Pröschel, M., Rao, M. S., & Rothstein, J. D. (2003) · Glia · doi:10.1002/glia.10310 · Cited by 87 · see citing works

Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity

Colton, C. K., Kong, Q., Lai, L., Zhu, M. X., Seyb, K. I., Cuny, G. D., Xian, J., Glicksman, M. A., & Lin, C.-L. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110370998 · Cited by 84 · see citing works

First Demonstration of a Functional Role for Central Nervous System Betaine/γ-Aminobutyric Acid Transporter (mGAT2) Based on Synergistic Anticonvulsant Action among Inhibitors of mGAT1 and mGAT2

White, H. S., Watson, W. P., Hansen, S. L., Slough, S., Perregaard, J., Sarup, A., Bolvig, T., Petersen, G., Larsson, O. M., Clausen, R. P., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068825 · Cited by 83 · see citing works

Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy

Marroni, M., Marchi, N., Cucullo, L., Abbott, N. J., Signorelli, K. L., & Janigro, D. (2003) · Current Drug Targets · doi:10.2174/1389450033491109 · Cited by 81 · see citing works

New views of glutamate transporter structure and function: advances and challenges

Jiang, J., & Amara, S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.019 · Cited by 78 · see citing works

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

Llorens, F., Thüne, K., Tahir, W., Kanata, E., Diaz-Lucena, D., Xanthopoulos, K., Kovatsi, E., Pleschka, C., Garcia-Esparcia, P., Schmitz, M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0226-4 · Cited by 249 · see citing works

Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes

Dolotov, O., Inozemtseva, L. S., Myasoedov, N., & Grivennikov, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094999 · Cited by 92 · see citing works

The Increased Densities, But Different Distributions, of Both C3 and S100A10 Immunopositive Astrocyte-Like Cells in Alzheimer’s Disease Brains Suggest Possible Roles for Both A1 and A2 Astrocytes in the Disease Pathogenesis

King, A., Szekely, B., Calapkulu, E., Ali, H., Rios, F., Jones, S., & Troakes, C. (2020) · Brain Sciences · doi:10.3390/brainsci10080503 · Cited by 89 · see citing works

The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions

Tarawneh, R. M., & Penhos, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104814 · Cited by 89 · see citing works

TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer’s disease

Tournier, B. B., Tsartsalis, S., Rigaud, D., Fossey, C., Cailly, T., Fabis, F., Pham, T., Grégoire, M.-C., Kövari, E., Moulin-Sallanon, M., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.022 · Cited by 62 · see citing works

Glutamatergic systems in neuropathic pain and emerging non-opioid therapies

Temmermand, R., Barrett, J. E., & Fontana, A. C. K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106492 · Cited by 59 · see citing works

Assessment of astrocytes as a mediator of memory and learning in rodents

Akther, S., & Hirase, H. (2021) · Glia · doi:10.1002/glia.24099 · Cited by 38 · see citing works

Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP + cells loss induced by restraint stress in mice

Perez-Urrutia, N., Mendoza, C., Alvarez-Ricartes, N., Oliveros-Matus, P., Echeverria, F., Grizzell, J. A., Barreto, G. E., Iarkov, A., & Echeverrı́a, V. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.016 · Cited by 34 · see citing works

Vitamin D3 repressed astrocyte activation following lipopolysaccharide stimulation in vitro and in neonatal rats

Jiao, K., Li, S., Wen-Yan, L. V., Ming-Liang, J. V., & He, H. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000782 · Cited by 30 · see citing works

Amyloid Fibril–Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses

Wu, J., Bie, B., Foss, J. F., & Naguib, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01885-7 · Cited by 28 · see citing works

Traditional herbal formula Jiao-tai-wan improves chronic restrain stress-induced depression-like behaviors in mice

Tang, Y., Wang, H., Nie, K., Gao, Y., Su, H., Wang, Z., Lu, F., Huang, W., & Dong, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113284 · Cited by 27 · see citing works

Charging Up the Periphery: Glial Ionic Regulation in Sensory Perception

Ray, S., & Singhvi, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.687732 · Cited by 18 · see citing works

Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development

Cacabelos, R., Naidoo, V., Martínez-Iglesias, O. A., Corzo, L., Cacabelos, N., Pego, R., & Carril, J. C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2573-6_13 · Cited by 19 · see citing works

Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection

Henao‐Restrepo, J., López‐Murillo, C., Valderrama‐Carmona, P., Orozco‐Santa, N., Gomez, J., Gutiérrez‐Vargas, J., Moraga, R., Toledo, J., Littau, J. L., Härtel, S., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13119 · Cited by 11 · see citing works

Functional abnormalities of the glymphatic system in cognitive disorders

Shentu, W., Kong, Q., Zhang, Y., Li, W., Chen, Q., Yan, S., Wang, J., Lai, Q., Qi, X., & Qiao, S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01049 · Cited by 9 · see citing works

In silico unraveling of molecular anti-neurodegenerative profile of Citrus medica flavonoids against novel pharmaceutical targets

Dehghan, M., Fathinejad, F., Farzaei, M. H., & Barzegari, E. (2022) · Chemical Papers · doi:10.1007/s11696-022-02496-3 · Cited by 9 · see citing works

Transport rate of EAAT2 is regulated by amino acid located at the interface between the scaffolding and substrate transport domains

Duffield, M. D., Patel, A., Mortensen, O. V., Schnur, D. M., Gonzalez-Suarez, A. D., Torres‐Salazar, D., & Fontana, A. C. K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104792 · Cited by 6 · see citing works

First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115

Chao, C., Blecha, J. E., Polvoy, I., Nillo, R. M., Seo, Y., Wilson, D. M., Forsayeth, J., VanBrocklin, H. F., & Gerdes, J. M. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.108992 · Cited by 5 · see citing works

A Novel Concept is Needed for Combating Alzheimer's Disease and NeuroHIV

Hu, X. (2020) · Alzheimers Disease & Dementia · doi:10.36959/734/377 · Cited by 4 · see citing works

The Conformationally Sensitive Spatial Distance Between the TM3-4 Loop and Transmembrane Segment 7 in the Glutamate Transporter Revealed by Paired-Cysteine Mutagenesis

Qu, Q., Wang, J., Li, G., Chen, R., & Qu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737629 · Cited by 1 · see citing works

Alzheimer’s Disease and Treatment: Calcium Dyshomeostasis in Medial Prefrontal Cortex Pyramidal Neurons

Hu, X. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_59-1 · Cited by 1 · see citing works

Conformationally Sensitive Proximity Between the TM3–4 Loop and Hairpin Loop 2 of the Glutamate Transporter EAAT2 Revealed by Paired-Cysteine Mutagenesis

Wang, J., & Qu, S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00645 · Cited by 1 · see citing works

Astrocyte-specific druggable protein as PET-ligand target for early detection of Alzheimer's disease

Sjöberg, R. (2017) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Plasma Human Cartilage Glycoprotein‐39 and Cognitive Impairment After Acute Ischemic Stroke

Wang, Z., Zhang, K., Zhong, C., Zhu, Z., Zheng, X., Yang, P., Che, B., Lu, Y., Zhang, Y., & Xu, T. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.036790

Alzheimer’s Disease and Treatment: Calcium Dyshomeostasis in Medial Prefrontal Cortex Pyramidal Neurons

Hu, X. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_59

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease

Zhang, X., Lao, K., Qiu, Z., Rahman, M. S., Zhang, Y., & Gou, X. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181084 · Cited by 23 · see citing works

Astrocyte: An Innovative Approach for Alzheimer's Disease Therapy

Bronzuoli, M. R., Facchinetti, R., Steardo, L., & Scuderi, C. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170710163411 · Cited by 20 · see citing works

Potential of astrocytes in targeting therapy for Alzheimer’s disease

Bi, W., Lei, T., Cai, S., Zhang, X., Yang, Y., Xiao, Z., Wang, L., & Du, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109368 · Cited by 13 · see citing works

Reactive Astrocytes as Drug Target in Alzheimer’s Disease

Assefa, B. T., Gebre, A. K., & Altaye, B. M. (2018) · BioMed Research International · doi:10.1155/2018/4160247 · Cited by 64 · see citing works

Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments

Rodríguez-Giraldo, M., González-Reyes, R. E., Ramírez-Guerrero, S., Bonilla-Trilleras, C. E., Guardo-Maya, S., & Nava-Mesa, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113630 · Cited by 118 · see citing works